THAP11

THAP11 (RONIN) is a THAP-domain zinc finger transcription factor that, in a mutually dependent complex with HCF-1 (HCFC1) and ZNF143 at CpG-island promoters, transcriptionally activates programs essential for ribosome biogenesis, mitochondrial energy production, cell-cycle progression, DNA repair, and cobalamin metabolism (PMID:18585351, PMID:20581084, PMID:25437553, PMID:35013307, PMID:28449119). It binds a hyperconserved ACTACA-containing DNA motif, where the spacing and orientation of this submotif relative to ZNF143-binding sequences dictate cooperative recruitment of THAP11 and HCF-1 to chromatin, and its C-terminal domain mediates homodimerization through a parallel coiled-coil structure (PMID:26416877, PMID:26975212). A THAP11 F80L missense mutation causes a cobalamin metabolism disorder through reduced MMACHC expression, and pathological polyglutamine expansion in THAP11 causes protein aggregation, gain-of-function transcriptional upregulation of TREM2, and TREM2/microglia-mediated cerebellar neurodegeneration (spinocerebellar ataxia type 51) (PMID:28449119, PMID:40459937). THAP11 also represses c-Myc transcription in a DNA-binding-dependent manner and modulates TFEB-driven autophagy/lysosomal activity in cochlear hair cells through its HCF-1 interaction (PMID:19008924, PMID:39985193).

1. 2008 High

   The foundational discovery that THAP11 physically binds HCF-1 and is essential for ES cell self-renewal and embryogenesis established it as a transcription factor at the core of pluripotency maintenance, while concurrent work showed it directly represses c-Myc transcription to suppress cell growth.

   Evidence Co-IP of RONIN–HCF-1, conditional knockout mouse ES cells, ectopic expression; ChIP/EMSA on c-Myc promoter with reporter and rescue assays

   PMID:18585351 PMID:19008924

   Open questions at the time

   • Genome-wide binding targets were unknown
   • Whether THAP11 acts primarily as an activator or repressor was unresolved
   • Structural basis of HCF-1 interaction was undefined
2. 2010 High

   Genome-wide ChIP-seq revealed that the RONIN/HCF-1 complex predominantly activates transcription at ACTACA-containing promoters of protein biosynthesis and energy metabolism genes, resolving the question of whether THAP11 is primarily an activator or repressor.

   Evidence ChIP-seq and expression profiling in ES cells

   PMID:20581084

   Open questions at the time

   • The precise DNA-binding motif grammar governing cooperative recruitment was not yet defined
   • Co-occupancy with other transcription factors was unknown
3. 2013 High

   Co-occupancy mapping showed THAP11 shares ~90% of HCF-1 binding sites at CpG-island promoters with ZNF143, and both factors recognize an overlapping ACTACA motif, establishing that THAP11 functions within a multi-factor hub rather than alone.

   Evidence ChIP-seq co-occupancy and motif analysis in HeLa cells; mutual dependency shown by reciprocal knockdown and ChIP in colon cancer cells

   PMID:22371484 PMID:23539139

   Open questions at the time

   • Mechanism of cooperative DNA binding between THAP11 and ZNF143 was unclear
   • Whether the complex directly regulates cell-cycle genes independently of E2F was untested
4. 2014 High

   Epistasis experiments demonstrated that THAP11 and ZNF143 cooperatively recruit HCF-1 to E2F-bound cell-cycle gene promoters independently of E2F, directly linking the THAP11/ZNF143/HCF-1 complex to cell-cycle control.

   Evidence ChIP, Co-IP, RNAi knockdown with cell-cycle analysis

   PMID:25437553

   Open questions at the time

   • The cis-regulatory grammar dictating THAP11 versus ZNF143 recruitment at shared motifs was unresolved
   • In vivo developmental consequences of disrupting this complex at specific loci were untested
5. 2015 High

   CRISPR editing of endogenous ACTACA submotifs proved that the position, spacing, and orientation of this element relative to ZNF143 core motifs are critical determinants of THAP11/HCF-1 recruitment and transcriptional output, establishing the cis-regulatory grammar.

   Evidence CRISPR-Cas9 promoter editing, synthetic reporter constructs, ChIP, histone modification analysis

   PMID:26416877

   Open questions at the time

   • Three-dimensional structure of THAP11 protein domains was unknown
   • Tissue-specific transcriptional programs regulated by THAP11 were unexplored
6. 2016 High

   Crystal structure of the THAP11 C-terminal domain revealed a parallel homodimeric coiled-coil, providing the first structural insight, while conditional knockout in retinal progenitors showed THAP11 positively regulates mitochondrial electron transport chain genes, linking it to energy metabolism in vivo.

   Evidence X-ray crystallography with biophysical validation; conditional knockout mouse retina with ETC activity, ATP, and oxidative stress assays

   PMID:26876175 PMID:26975212

   Open questions at the time

   • Structure of the THAP zinc-finger domain bound to DNA was still lacking
   • Whether mitochondrial regulation is a general or tissue-specific THAP11 function was unclear
7. 2017 High

   A human THAP11 F80L mutation was identified as causative for a cobalamin metabolism disorder via reduced MMACHC expression, and THAP11 was shown to regulate DNA repair genes (Gtf2h4, Rad18), broadening the functional scope beyond metabolism and cell cycle to include disease and genome maintenance.

   Evidence Patient sequencing with zebrafish loss-of-function validation and RNA-seq; conditional KO ES cells with UV-C treatment and ChIP

   PMID:28449119 PMID:28715716

   Open questions at the time

   • Whether additional cobalamin-disorder patients carry THAP11 mutations was unknown
   • Relative contribution of DNA repair versus metabolic programs to THAP11 phenotypes was unresolved
8. 2021 Medium

   In vivo studies demonstrated that THAP11 governs the metabolic/proliferative transition during implantation by regulating ribosomal protein gene expression, and that overexpression in Purkinje cells causes ataxia through deregulation of SCA-associated gene loci including Ataxin-1.

   Evidence Conditional knockout mouse embryos with metabolic and RNA-seq analysis; transgenic Purkinje cell-specific overexpression mouse with ChIP and Western blot

   PMID:34165550 PMID:34515391

   Open questions at the time

   • Whether Purkinje cell degeneration is due to gain of THAP11 transcriptional activity or aggregation was unresolved
   • Direct binding of THAP11 to ribosomal protein gene promoters in embryos was not shown by ChIP
9. 2022 High

   Multi-omic analysis in mouse models confirmed that HCFC1/THAP11 jointly regulate ribosomal protein subunit genes and ribosome biogenesis during development, establishing a unified model where metabolic defects in HCFC1/THAP11 disorders converge on translational insufficiency.

   Evidence Mouse knockout models with RNA-seq, ribosome profiling, and metabolic analysis

   PMID:35013307

   Open questions at the time

   • Whether ribosome biogenesis regulation is separable from cobalamin metabolic regulation at the chromatin level was unknown
   • Therapeutic strategies to restore ribosome biogenesis in THAP11-deficient contexts were unexplored
10. 2025 High

    PolyQ-expanded THAP11 was shown to cause cerebellar neurodegeneration through a gain-of-function mechanism involving protein aggregation, transcriptional upregulation of TREM2, and TREM2-mediated microglial activation; genetic ablation of TREM2 or microglial depletion rescued neurodegeneration, establishing a non-cell-autonomous pathogenic mechanism for SCA51.

    Evidence SCA51 knockin mouse, AAV expression in monkeys, TREM2 KO epistasis, microglial depletion, ChIP at TREM2 promoter

    PMID:40459937

    Open questions at the time

    • Whether wild-type THAP11 normally regulates TREM2 or this is purely a neomorphic activity is unclear
    • The polyQ threshold for aggregation and gain-of-function has not been precisely defined
    • Whether the TREM2-microglial mechanism applies to other polyQ-expansion ataxias is unknown
11. 2025 Medium

    THAP11 was found to modulate TFEB transcriptional activity through HCF-1, controlling autophagy and lysosomal biogenesis in cochlear hair cells, extending its regulatory reach to lysosomal homeostasis.

    Evidence Co-IP of RONIN–HCF1, overexpression in hair cells with autophagy/lysosomal activity assays

    PMID:39985193

    Open questions at the time

    • Whether THAP11 directly binds TFEB or acts indirectly through HCF-1 was not resolved
    • In vivo hearing phenotype from THAP11 loss in cochlear cells was not reported

• The structure of the THAP zinc-finger domain bound to its ACTACA DNA target, the precise mechanism by which THAP11 cooperates with ZNF143 at shared motifs in three dimensions, and whether the ribosome biogenesis and cobalamin metabolism programs are regulated by separable chromatin complexes remain unresolved.
• No co-crystal structure of THAP domain with DNA exists
• Separation-of-function alleles distinguishing ribosome biogenesis from cobalamin regulation have not been generated
• The full spectrum of THAP11 disease-causing mutations and genotype-phenotype correlations is incomplete